amiodarone has been researched along with Tremor in 12 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 7.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
| "Amiodarone is an antiarrhythmic drug with a significant adverse effect profile, including neurotoxicity." | 7.01 | Amiodarone-Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports. ( Dumic, I; Kaur, A; Kaur, P; Khaliq, W; Singh, A; Sinha, A, 2023) |
| "One hundred two patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for nine +/- eight months (mean +/- SD) (range, one to 50 months)." | 3.67 | Unusual neurotoxicity associated with amiodarone therapy. ( Iyer, V; Meckler, RJ; Palakurthy, PR, 1987) |
| "Amiodarone, a drug used to treat refractory cardiac arrhythmias, produced a peripheral neuropathy in 5 of 50 cases (10%)." | 3.66 | Amiodarone neuropathy. ( Martinez-Arizala, A; McCarty, GE; Nichols, BR; Rakita, L; Sobol, SM, 1983) |
| "Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 3.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
| "Amiodarone is an antiarrhythmic drug with a significant adverse effect profile, including neurotoxicity." | 3.01 | Amiodarone-Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports. ( Dumic, I; Kaur, A; Kaur, P; Khaliq, W; Singh, A; Sinha, A, 2023) |
| "Amiodarone has been used for the last 20 years, initially as antianginal and then as antiarrhythmic agent." | 1.28 | [Optic neuropathy caused by amiodarone]. ( Ferreiro, JL; Isern Longares, JA; Ramón Moya, AF, 1990) |
| "Paraesthesiae, ataxia, vertigo and tremor were the most common (7-9%)." | 1.28 | Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme. ( Coulter, DM; Edwards, IR; Savage, RL, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, P | 1 |
| Kaur, A | 1 |
| Sinha, A | 1 |
| Khaliq, W | 1 |
| Dumic, I | 1 |
| Singh, A | 1 |
| Nogueras, C | 1 |
| Miralles, R | 1 |
| Roig, A | 1 |
| Llorach, I | 1 |
| Cervera, AM | 1 |
| Martinez-Arizala, A | 1 |
| Sobol, SM | 1 |
| McCarty, GE | 1 |
| Nichols, BR | 1 |
| Rakita, L | 1 |
| Charness, ME | 1 |
| Morady, F | 2 |
| Scheinman, MM | 2 |
| Sauve, MJ | 1 |
| Malone, P | 1 |
| Shen, EN | 1 |
| Schwartz, AB | 1 |
| Bhandari, A | 1 |
| Keung, E | 1 |
| Sung, RJ | 1 |
| Kulbertus, HE | 1 |
| Demoulin, JC | 1 |
| Bertholet, M | 1 |
| Bady, B | 1 |
| Bourrat, C | 1 |
| Trillet, M | 1 |
| Girard, PF | 1 |
| Carrier, H | 1 |
| Ferreiro, JL | 1 |
| Isern Longares, JA | 1 |
| Ramón Moya, AF | 1 |
| Coulter, DM | 1 |
| Edwards, IR | 1 |
| Savage, RL | 1 |
| Della Sala, S | 1 |
| Marchetti, C | 1 |
| Palakurthy, PR | 1 |
| Iyer, V | 1 |
| Meckler, RJ | 1 |
| Anderson, NE | 1 |
| Lynch, NM | 1 |
| O'Brien, KP | 1 |
2 reviews available for amiodarone and Tremor
| Article | Year |
|---|---|
Amiodarone-Induced Nystagmus and Ataxia: Case Report and Systematic Review of Case Reports.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Ataxia; Atrial Fibrillation; Dizziness; Drug- | 2023 |
[Toxic neurologic manifestations during angina pectoris treatment (perhexiline maleate and amiotadone hydrochloride)].
Topics: Amiodarone; Angina Pectoris; Benzofurans; Cerebrospinal Fluid Proteins; Electromyography; Humans; In | 1978 |
10 other studies available for amiodarone and Tremor
| Article | Year |
|---|---|
Polypharmacy as part of comprehensive geriatric assessment: disclosure of false diagnosis of atrial fibrillation by drug revision.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Artifacts; Aspirin; Atrial Fibrillation; Diagnostic Errors | 2007 |
Amiodarone neuropathy.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle Aged; Nervous Syst | 1983 |
Frequent neurologic toxicity associated with amiodarone therapy.
Topics: Amiodarone; Ataxia; Benzofurans; Female; Humans; Male; Middle Aged; Nervous System Diseases; Tremor | 1984 |
Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Topics: Aged; Amiodarone; Anorexia; Ataxia; Benzofurans; Female; Heart Arrest; Humans; Lung Diseases; Male; | 1983 |
[Amiodarone: review of its antianginal properties and analysis of side effects].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Coronary Vessels; | 1982 |
[Optic neuropathy caused by amiodarone].
Topics: Amiodarone; Animals; Cardiac Complexes, Premature; Demyelinating Diseases; Humans; Male; Middle Aged | 1990 |
Survey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring Programme.
Topics: Amiodarone; Ataxia; Humans; Nervous System Diseases; New Zealand; Paresthesia; Product Surveillance, | 1990 |
Tremor: a possible side effect of prolonged therapy with low doses of amiodarone.
Topics: Aged; Amiodarone; Humans; Male; Masseter Muscle; Masticatory Muscles; Tremor | 1989 |
Unusual neurotoxicity associated with amiodarone therapy.
Topics: Aged; Amiodarone; Brain Diseases; Brain Stem; Female; Humans; Jaw; Male; Middle Aged; Movement Disor | 1987 |
Disabling neurological complications of amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Biopsy; Electromyography; Female; Gait; Humans; Male; Muscle Hypotoni | 1985 |